Akero Therapeutics, Inc. Contracts & Agreements
26 Contracts & Agreements
- Business Finance (15 contracts)
- Business Operations (1)
- Human Resources (7)
- Real Estate (1)
- Uncategorized (2)
- Warrant Agreement, by and between Akero Therapeutics, Inc. and Hercules Private Credit Fund 1 L.P., dated March 12, 2024 (Filed With SEC on March 18, 2024)
- Underwriting Agreement, dated as of March 5, 2024, by and between the Company, J.P. Morgan, Morgan Stanley, Jefferies, and Evercore, as representatives of the several underwriters... (Filed With SEC on March 6, 2024)
- Underwriting Agreement, dated as of May 16, 2023, by and between the Company and Jefferies LLC, as representative of the several underwriters named therein (Filed With SEC on May 17, 2023)
- Open Market Sale AgreementSM, by and between Akero Therapeutics, Inc. and Jefferies LLC, dated March 17, 2023 (Filed With SEC on March 17, 2023)
- Underwriting Agreement, dated as of September 14, 2022, by and between the Company, J.P. Morgan, Morgan Stanley and Jefferies, as representatives of the several underwriters named... (Filed With SEC on September 16, 2022)
- Warrant, dated June 15, 2022 by and between the Registrant and Hercules Capital, Inc (Filed With SEC on August 5, 2022)
- Warrant, dated June 15, 2022 by and between the Registrant and Hercules Private Global Venture Growth Fund I L.P (Filed With SEC on August 5, 2022)
- Loan and Security Agreement dated as of June 15, 2022 by and between the Registrant and Hercules Capital, Inc (Filed With SEC on August 5, 2022)
- Securities Purchase Agreement dated as of June 15, 2022 by and between Akero Therapeutics, Inc. and Pfizer Inc (Filed With SEC on June 16, 2022)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 25, 2022)
- Form of Underwriting Agreement (Filed With SEC on July 6, 2020)
- Description of Securities (Filed With SEC on March 16, 2020)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 16, 2020)
- Form of Underwriting Agreement (Filed With SEC on June 10, 2019)
- Amended and Restated Employment Agreement for William White (Filed With SEC on June 10, 2019)
- Amended and Restated Employment Agreement for Andrew Cheng (Filed With SEC on June 10, 2019)
- Form of Amended and Restated Employment Agreement for Executive Officers (Filed With SEC on June 10, 2019)
- Non-Employee Director Compensation Policy (Filed With SEC on June 10, 2019)
- 2019 Employee Stock Purchase Plan (Filed With SEC on June 10, 2019)
- 2019 Stock Option and Grant Plan, and form of award agreements thereunder (Filed With SEC on June 10, 2019)
- Specimen Common Stock Certificate (Filed With SEC on June 10, 2019)
- Sublease Agreement between the Registrant and Trucode Gene Repair, Inc., dated October 23, 2018, as amended by the First Amendment to Sublease Agreement, dated as of February 27,... (Filed With SEC on May 24, 2019)
- 2019 Senior Executive Cash Bonus Plan (Filed With SEC on May 24, 2019)
- Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Filed With SEC on May 24, 2019)
- 2018 Stock Option and Grant Plan, amendments thereto, and form of award agreements thereunder (Filed With SEC on May 24, 2019)
- Amended and Restated Investors' Rights Agreement among the Registrant and certain of its stockholders, dated December 5, 2018 (Filed With SEC on May 24, 2019)